Key result
Midsystolic Doppler signal void in HCM linked to ~17-fold higher odds of apical aneurysm.
Why the study?
Standardized echocardiographic criteria for midapical obstruction in HCM remain limited, and its pathophysiologic and prognostic implications are incompletely defined.
Does the presence of a midsystolic Doppler signal void identify adverse structural remodeling and high-risk features in patients with hypertrophic cardiomyopathy?
Observational (n=606)
Does the presence of a midsystolic Doppler signal void identify adverse structural remodeling and high-risk features in patients with hypertrophic cardiomyopathy?
Midsystolic Doppler signal void is a useful echocardiographic marker to identify a distinct midapical obstructive phenotype in HCM associated with apical aneurysms and reduced global longitudinal strain.
Answers are grounded in this paper and cite their sources.
May flag high-risk midapical HCM on echo but should not yet change practice; leaves open prospective validation of Doppler signal void.
BACKGROUND: Midapical obstruction in hypertrophic cardiomyopathy (HCM) represents a distinct anatomic and hemodynamic phenotype. However, standardized echocardiographic criteria for its identification remain limited, and its pathophysiologic and prognostic implications are incompletely defined. METHODS: The authors studied 606 consecutive patients with HCM, stratified by the presence or absence of a midsystolic Doppler signal void, defined as a continuous-wave Doppler manifestation of systolic cavity obliteration. Left ventricular (LV) morphology, intracavitary flow characteristics, the prevalence of apical aneurysm, circulating cardiac troponin I levels, and LV global longitudinal strain (GLS) were systematically assessed. RESULTS: A midsystolic Doppler signal void was present in 142 patients (23.4%). Compared with patients without signal void, these patients exhibited more pronounced midapical hypertrophy and papillary muscle hypertrophy, smaller indexed LV end-diastolic volumes, and higher peak midapical Doppler gradients. They also had a higher prevalence of apical aneurysm, higher cardiac troponin I levels, and lower absolute LV GLS. In multivariable analysis, apical aneurysm (OR, 17.27; 95% CI, 2.30-129.60; P = .006) and lower |GLS| (OR, 0.71; 95% CI, 0.58-0.89; P = .002) remained independently associated with Doppler signal void. CONCLUSIONS: Midsystolic Doppler signal void identifies a distinct midapical obstructive phenotype in HCM and may complement conventional gradient-based assessment by identifying patients with adverse structural remodeling and high-risk features.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted an observational in Hypertrophic cardiomyopathy (n=606). Midsystolic Doppler signal void vs. Absence of midsystolic Doppler signal void was evaluated on Apical aneurysm (OR 17.27, 95% CI 2.30-129.60, p=.006). A midsystolic Doppler signal void in hypertrophic cardiomyopathy was independently associated with apical aneurysm and lower absolute LV GLS.
Synapse has enriched 10 related papers. Consider them for comparative context: